Published in Neural Regen Res on April 01, 2017
Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res (2010) 5.08
MicroRNAs regulate ocular neovascularization. Mol Ther (2008) 1.89
MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci (2011) 1.39
microRNA in the development of diabetic complications. Clin Sci (Lond) (2014) 1.10
miR-195 regulates SIRT1-mediated changes in diabetic retinopathy. Diabetologia (2014) 1.06
Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment. Cardiovasc Diabetol (2014) 0.95
MicroRNA therapeutics: Discovering novel targets and developing specific therapy. Perspect Clin Res (2016) 0.94
miR-15b/16 protects primary human retinal microvascular endothelial cells against hyperglycemia-induced increases in tumor necrosis factor alpha and suppressor of cytokine signaling 3. J Neuroinflammation (2015) 0.92
miR-146a Attenuates Inflammatory Pathways Mediated by TLR4/NF-κB and TNFα to Protect Primary Human Retinal Microvascular Endothelial Cells Grown in High Glucose. Mediators Inflamm (2016) 0.92
Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2014) 0.90
Dietary delivery: a new avenue for microRNA therapeutics? Trends Biotechnol (2015) 0.88
miR-15a/16 reduces retinal leukostasis through decreased pro-inflammatory signaling. J Neuroinflammation (2016) 0.81